Immunocore
Based in Abingdon (UK) and Philadelphia (USA) Immunocore is a privately owned biotechnology company developing innovative biological therapeutics for the treatment of a range of serious diseases. Its world-leading T cell receptor technology exploits the power of the body’s own immune system to find and kill diseased cells.